ACP-TX-II PLA2 did not show toxicity in non-tumor cells used in this study, and 250–500 μg were required to decrease A549 tumor cell viability by 20 to 25% compared to controls, but the difference was not statistically significant (Figure 7B). This evidence concerns the gene PLA2G2A and neoplasm.